Open AccessMedication related osteonecrosis of the jaws (MRONJ): Factors related to recurrence after treatment with surgery and platelet rich plasma (PRP) placement
Author(s) -
C Sánchez-Gallego Albertos,
J-L Del Castillo Pardo de Vera,
Aurora Viejo Llorente,
José Luis Cebrián Carretero
Publication year - 2021
Publication title -
medicina oral, patología oral y cirugía bucal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.644
H-Index - 56
eISSN - 1698-6946
pISSN - 1698-4447
DOI - 10.4317/medoral.24007
Subject(s) - medicine , osteonecrosis of the jaw , zoledronic acid , denosumab , retrospective cohort study , surgery , multivariate analysis , osteoporosis , debridement (dental) , multiple myeloma , bisphosphonate
Medication-related osteonecrosis of the jaws (MRONJ) is a well-known complication associated with antiresorptive and antiangiogenic therapies. The purpose of this study was to analyse if there is any predictive factor of recurrence after local debridement plus platelet rich plasma (PRP) placement in MRONJ patients.